medigraphic.com
SPANISH

Revista Cubana de Urología

ISSN 2305-7939 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

RCU 2022; 11 (1)

Behavior of residual lithiasis in patients treated with percutaneous nephrolithotomy due to coralliform kidney stone

Castillo RM, González LT, Castillo LR, Gutiérrez RAR, Borrero BLL, Ramírez MA
Full text How to cite this article

Language: Spanish
References: 25
Page: 49-61
PDF size: 373.90 Kb.


Key words:

urinary lithiasis, coralliform lithiasis, percutaneous nephrolithotomy, residual litiasis.

ABSTRACT

Introduction: Residual urinary lithiasis, after percutaneous nephrolithotomy, can generate recurrence of the disease.
Objective: Describe the evolution of patients with residual lithiasis after percutaneous nephrolithotomy due to coralliform lithiasis.v Methods: A descriptive, longitudinal and prospective study was conducted in 191 patients operated on by percutaneous nephrolithotomy with rigid instruments and pneumatic lithotritor, in the Lithotripsy and Endourology Unit of “Hermanos Ameijeiras” Hospital, between August 2005 and January 2010. Patients with residual lithiasis were followed until December 2020. The variables considered were: sex, age, type of coralliform treated, residual lithiasis, recurrence, its characteristics, complications, need and type of treatment. Absolute, relative and mean frequencies were found.
Results: 33 patients (17.3 %) presented residual lithiasis; of these, 63.6% had been treated for total coralliform and 45.5% had follow-up for 62 months. Residual lithiasis predominated between 7 and 9 mm in the lower and single calyx. Recurrence occurred in 99.3%, and it was of renal localization (80%), which manifested as urinary tract infection in 46.6%. Recurrent lithiasis required nephrectomy treatment in 26.6% of cases, and 46.6% of patients progressed with kidney damage.
Conclusions: It is essential to apply a therapeutic strategy that minimizes the rate of residual lithiasis after percutaneous nephrolithotomy of coralliform lithiasis to prevent its negative impact on the recurrence of the disease, the need for new treatments and damage of renal function.


REFERENCES

  1. Romano J, Estrada C, Suárez N. Coraliform lithiasis. Aten Primaria. 2019 [acceso04/04/2021];51(7):452-3. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837120/

  2. Diri A, Diri B. Management of staghorn renal stones. Ren Fail. 2018 [acceso 15/11/2021];40(1):357-62. Disponible en: https://www.tandfonline.com/doi/full/10.1080/0886022X.2018.1459306

  3. Torricelli FCM, Monga M. Staghorn renal stones: what the urologist needs to know. Int Braz J Urol.2020 [acceso 15/06/2021];46(6):927-33. Disponible en:https://www.scielo.br/j/ibju/a/gwsL8GjxrGHsZmLYjTPfxTw/?lang=en

  4. Arrabal Martín M, Cano García MC, Arrabal Polo M, Domínguez Amillo A, Canales Casco N, de la TorreTrillo J, et al. Etiopathogenic factors of the different types of urinary litiasis. Arch Esp Urol. 2017[acceso 15/06/2021];70(1):40-50. Disponible en:http://www.aeurologia.com/articulo_prod.php?id_art=671814580763

  5. Lancina Martín JA. Metabolic study. How to make it accessible, useful and generalized. Arch Esp Urol.2017 [acceso 15/06/2021];70(1):71-90. Disponible en:http://www.aeurologia.com/articulo_prod.php?id_art=481871318567

  6. Preminger GM. High burden and complex renal calculi: aggressive percutaneous nephrolithotomyversus multi-modal approaches. Arch Ital Urol Androl. 2010 [acceso 12/06/2021];82(1):37-40.Disponible en: https://pubmed.ncbi.nlm.nih.gov/20593717/

  7. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS, Jr. Chapter 1: AUA guidelineon management of staghorn calculi: diagnosis and treatment recommendations. J Urol. 2005 [acceso12/06/2021];173(6):1991-2000. Disponible en:https://www.auajournals.org/doi/10.1097/01.ju.0000161171.67806.2a

  8. Castillo CO, Pinto GI, Díaz CM, Vitagliano G, Fonerón VA, Vidal MI, et al. Cirugía percutánea de lalitiasis coraliforme. Rev Chil Cir. 2008 [acceso 23/09/2021]; 60:393-7. Disponible en:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262008000500005&nrm=iso

  9. Chen FT, Liu FC, Cheng CW, Lin JR, Yu HP. Postoperative renal outcomes of patients receivingpercutaneous nephrolithotomy versus pyelolithotomy: a population-based cohort study. Biomed ResInt. 2018 [acceso 12/06/2021];2018:8582901. Disponible en:http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5954950/

  10. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone diseaseacross the world. World J Urol. 2017;35(9):1301-20. DOI: https://doi.org/10.1007/s00345-017-2008-6

  11. Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis. Investig Clin Urol. 2017[acceso 12/09/2021];58(5):299-306. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577325/

  12. Joshi R. Complications and success rate of percutaneous nephrolithotomy in renal stone: adescriptive cross-sectional study. JNMA J Nepal Med Assoc. 2019 [acceso 12/06/2021];57(220):444-8. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7580408/

  13. Wang W, Fan J, Huang G, Li J, Zhu X, Tian Y, et al. Prevalence of kidney stones in mainland China: Asystematic review. Sci Rep. 2017 [acceso 12/06/2021];7:41630. Disponible en:http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5282506/

  14. Ganpule AP, Naveen Kumar Reddy M, Sudharsan SB, Shah SB, Sabnis RB, Desai MR. Multitractpercutaneous nephrolithotomy in staghorn calculus. Asian J Urol. 2020 [acceso 12/06/2021];7(2):94-101. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7096673/

  15. Chung DY, Kang DH, Cho KS, Jeong WS, Jung HD, Kwon JK, et al. Comparison of stone-free ratesfollowing shock wave lithotripsy, percutaneous nephrolithotomy, and retrograde intrarenal surgeryfor treatment of renal stones: A systematic review and network meta-analysis. PloS One. 2019[acceso 12/06/2021];14(2):e0211316. DOI: https://doi.org/10.1371/journal.pone.0211316.

  16. Ermis O, Somani B, Reeves T, Guven S, Pes PL, Chawla A, et al. Definition, treatment and outcome ofresidual fragments in staghorn stones. Asian J Urol. 2020 [acceso 12/06/2021];7(2):116-21.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7096689/

  17. He XZ, Ou TW, Cui X, Li J, Wang SH. Analysis of the safety and efficacy of combined extracorporealshock wave lithotripsy and percutaneous nephrolithotomy for the treatment of complex renalcalculus. European review for medical and pharmacological sciences. 2017 [acceso12/06/2021];21(11):2567-71. Disponible en: http://www.europeanreview.org/article/12874

  18. Opondo D, Gravas S, Joyce A, Pearle M, Matsuda T, Sun YH, et al. Standardization of patient outcomesreporting in percutaneous nephrolithotomy. J Endourol. 2014 [acceso 12/06/2021];28(7):767-74.DOI: https://doi.org/10.1089/end.2014.0057

  19. de la Rosette JJ, Opondo D, Daels FP, Giusti G, Serrano A, Kandasami SV, et al. Categorisation ofcomplications and validation of the Clavien score for percutaneous nephrolithotomy. Europ Urol.

  20. 2012 [acceso: 12/06/2021];62(2):246-55. DOI: https://doi.org/10.1016/j.eururo.2012.03.05520. de Souza Melo PA, Vicentini FC, Beraldi AA, Hisano M, Murta CB, de Almeida Claro JF. Outcomes ofmore than 1 000 percutaneous nephrolithotomies and validation of Guy's Stone Score. BJU Int. 2018[acceso 12/06/2021];121(4):640-6. DOI: https://doi.org/10.1111/bju.14129

  21. Ganpule A, Desai M. Fate of residual stones after percutaneous nephrolithotomy: a critical analysis.J Endourol. 2009 [acceso 12/06/2021];23(3):399-403. DOI: https://doi.org/10.1089/end.2008.0217

  22. Shah C, Basnet RB, Shah A, Chhettri P, Chapagain A, Shrestha PM, et al. Stone clearance by computedtomography after percutaneous nephrolithotomy: A descriptive cross-sectional study. JNMA J NepalMed Assoc. 2020 [acceso 12/06/2021];58(228):587-90. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580361/

  23. Harraz AM, Osman Y, El-Nahas AR, Elsawy AA, Fakhreldin I, Mahmoud O, et al. Residual stones afterpercutaneous nephrolithotomy: comparison of intraoperative assessment and postoperative noncontrastcomputerized tomography. World J Urol. 2017 [acceso 12/06/2021];35(8):1241-6. DOI:https://doi.org/10.1007/s00345-016-1990-4

  24. Akman T, Binbay M, Kezer C, Yuruk E, Tekinarslan E, Ozgor F, et al. Factors affecting kidney functionand stone recurrence rate after percutaneous nephrolithotomy for staghorn calculi: outcomes of along-term followup. J Urol. 2012 [acceso 12/06/2021];187(5):656-61. DOI:https://doi.org/10.1016/j.juro.2011.12.061

  25. El-Nahas AR, Eraky I, Shokeir AA, Shoma AM, El-Assmy AM, El-Tabey NA, et al. Long-term results ofpercutaneous nephrolithotomy for treatment of staghorn stones. BJU Int. 2011 [acceso12/06/2021];108(5):750-4. DOI: https://doi.org/10.1111/j.1464-410x.2010.09942.x




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

RCU. 2022;11